CEMIPLIMAB for Metastatic squamous cell carcinoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 34 adverse event reports in the FDA FAERS database where CEMIPLIMAB was used for Metastatic squamous cell carcinoma.
Most Reported Side Effects for CEMIPLIMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 68 | 6.7% | 8 | 34 |
| Pyrexia | 49 | 4.8% | 9 | 41 |
| Pneumonia | 41 | 4.0% | 3 | 34 |
| Dyspnoea | 40 | 3.9% | 7 | 28 |
| Pneumonitis | 38 | 3.7% | 15 | 25 |
| Off label use | 35 | 3.4% | 11 | 19 |
| Diarrhoea | 34 | 3.3% | 3 | 12 |
| Rash | 34 | 3.3% | 1 | 13 |
| Cytokine release syndrome | 33 | 3.2% | 5 | 30 |
| Pain | 33 | 3.2% | 4 | 16 |
| Asthenia | 32 | 3.1% | 5 | 21 |
| Nausea | 31 | 3.0% | 1 | 12 |
| Anaemia | 30 | 2.9% | 9 | 27 |
| Disease progression | 30 | 2.9% | 11 | 11 |
| Drug ineffective | 30 | 2.9% | 8 | 15 |
Other Indications for CEMIPLIMAB
Squamous cell carcinoma of skin (245)
Squamous cell carcinoma (80)
Product used for unknown indication (62)
Non-small cell lung cancer (51)
Neoplasm malignant (47)
Non-small cell lung cancer stage iv (41)
Basal cell carcinoma (38)
Lung adenocarcinoma stage iv (37)
Malignant melanoma (34)
Cervix carcinoma (27)
Other Drugs Used for Metastatic squamous cell carcinoma
PEMBROLIZUMAB (122)
CARBOPLATIN (118)
PACLITAXEL (86)
NIVOLUMAB (82)
CETUXIMAB (60)
FLUOROURACIL (48)
CEMIPLIMAB-RWLC (42)
CISPLATIN (36)
DOCETAXEL (24)
GEMCITABINE (23)